Survival outcomes of mucosal melanoma in the USA

Future Oncol. 2019 Dec;15(34):3977-3986. doi: 10.2217/fon-2019-0465. Epub 2019 Nov 14.

Abstract

Background: Mucosal melanomas (MM) arise within the lining of the gastrointestinal (GI), genitourinary (GU) and head and neck (HN) systems. Method: A retrospective analysis of the National Comprehensive Database identified 4,961 MM patients. Primary objective was to compare survival outcomes across the different locations. Results: Overall survival for GI melanomas was significantly shorter than HN and GU melanomas. Median survival (95% confidence interval) was 19.5 (18.0-21.5), 26.4 (24.9-28.3), and 43.9 (38.8-47.8), months for GI, HN and GU cases, respectively (p<0.0001). Conclusion: This is the largest study of MM in a US based population, demonstrating worse overall survival for GI MM in comparison to HN and GU melanomas.

Keywords: gastrointestinal melanomas; genitourinary melanomas; head and neck melanomas; mucosal melanoma.

Publication types

  • Comparative Study

MeSH terms

  • Aged
  • Aged, 80 and over
  • Female
  • Follow-Up Studies
  • Gastrointestinal Neoplasms / mortality*
  • Gastrointestinal Neoplasms / pathology
  • Gastrointestinal Neoplasms / therapy
  • Head and Neck Neoplasms / mortality*
  • Head and Neck Neoplasms / pathology
  • Head and Neck Neoplasms / therapy
  • Humans
  • Kaplan-Meier Estimate
  • Male
  • Melanoma / mortality*
  • Melanoma / pathology
  • Melanoma / therapy
  • Middle Aged
  • Mucous Membrane / pathology*
  • Sex Factors
  • Survival Rate
  • Treatment Outcome
  • United States / epidemiology
  • Urogenital Neoplasms / mortality*
  • Urogenital Neoplasms / pathology
  • Urogenital Neoplasms / therapy